GlassScriptPhysician profile
Daniel W Kim
NPI 1437507274
$405,931.10
in general payments reported to CMS, 2019-2025
27 companies · $261K in 2025
The $261K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $826 · 2023: $69K · 2024: $75K · 2025: $261K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $174K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $168K · Food and Beverage: $33K · Travel and Lodging: $19K · Honoraria: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $173,521.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $167,860.00 |
| Food and Beverage | $32,728.28 |
| Travel and Lodging | $19,061.76 |
| Honoraria | $11,673.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $153,472.61 | 2024-2025 | Barrigel, Urolift |
| Bioprotect Medical, INC. | $83,949.87 | 2024-2025 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $59,034.34 | 2022-2023 | |
| Gt Medical Technologies, INC | $49,293.15 | 2023-2025 | Gammatile, Gammatile |
| Novocure INC. | $40,618.85 | 2021-2025 | Optune Gio, Optune, Optune Lua (Novottf-200t) |
| Novartis Pharmaceuticals Corporation | $7,039.02 | 2024-2025 | |
| Izi Medical Products, LLC | $4,000.00 | 2025 | |
| Blue Earth Diagnostics | $1,423.29 | 2023-2024 | |
| Elekta, INC. | $1,115.35 | 2024 | Elekta Medical Linear Accelerator, Elekta Unity |
| Theragenics Corporation | $1,095.31 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $636.16 | 2024-2025 | Varian Ethos Treatment Planning, Truebeam |
| Angiodynamics, INC. | $631.87 | 2023-2025 | Nanoknife |
| Telix Pharmaceuticals | $480.26 | 2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $449.49 | 2022-2024 | Pylarify |
| Boston Scientific Corporation | $448.82 | 2023-2025 | Spaceoar Vue System - 10ml |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtec LLC | $368.72 | 2024 | |
| Myriad Genetic Laboratories, INC. | $357.22 | 2022-2025 | Prolaris |
| Isoray, INC | $336.90 | 2023-2024 | Brachytherapy Source |
| Galvanize Therapeutics, INC | $185.43 | 2024 | Aliya System |
| Arrow International, INC. | $162.30 | 2024 | |
| Zap Surgical Systems, INC. | $148.06 | 2024 | Zap-X Treatment Delivery Software, Zap-X Radiosurgery System, Zap-X Treatment Planning Software |
| Bard Peripheral Vascular, INC. | $143.77 | 2024 | Model 200 Theraseed Palladium-103 In Readylink |
| Janssen Scientific Affairs, LLC | $118.65 | 2025 | Erleada |
| Sirtex Medical INC | $109.99 | 2023 | Sir-Spheres Microspheres |
| Longeviti Neuro Solutions INC | $105.48 | 2025 | Clearfit |
| Philips North America LLC | $104.15 | 2024-2025 | (Dv6) Ei Sales Nam, Disease Management Solutions Equipment Undivided |
| Sumitomo Pharma America, INC. | $102.04 | 2023 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.